5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Mass Spectrometry Market is segmented by Technology (Hybrid Mass Spectrometry, Single Mass Spectrometry, and Other Mass Spectrometry), Application, and Geography.
Fastest Growing Market:
The mass spectrometry market is expected to witness a CAGR of 7.27% over the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.
Mass spectrometry (MS) is one of the most powerful tools used for the analyses of a wide range of chemical and biological entities. In addition, the high demand and resulting requirements from the pharmaceutical and biotechnology industries are the main driving factors for some extraordinary recent advances in mass spectrometry technology. The advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools and software has the potential to stimulate the usage of mass spectroscopy across drug development, proteomics, pharmaceuticals, food safety testing, and many other fields. The demands of the life sciences applications have led to the improvement of MS technologies and the rapid growth of new types of instruments. New mass spectrometry methods, collectively known as data independent analysis and hyper reaction monitoring, have recently emerged. Understanding complexity related to cancer biology requires extensive information about the cancer proteome over the course of the disease. Hence, with the increasing technological advancement, the market is expected to grow.
As per the scope of this report, mass spectrometry (MS) is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample, by measuring the mass-to-charge ratio and abundance of gas-phase ions.
|Other Mass Spectrometry|
Report scope can be customized per your requirements. Click here.
Tandem mass spectrometry devices are currently among the most in-demand. Conventional hospital diagnostic assays are based on clinical chemistry and immunoassay techniques that require analyte-specific reagents and antibodies. LC-MS/MS-based approaches are considered reagent-free. The high specificity and sensitivity of LC-MS/MS overcome many limitations associated with the traditional immunoassays, such as non-specific antibody binding and cross-reactivity. There is a higher demand for hybrid instruments, such as triple quadrupole mass spectrometer, quadrupole time-of-flight mass spectrometer, etc. Currently, triple quadrupole MS is considered one of the most high-end instruments, and many labs across the world are adopting this instrument.
To understand key trends, Download Sample Report
Research and development include drug development and fundamental science research. Drug development, from the initial discovery to the final medication, is an expensive and lengthy process, and the failure rate is also high. High cost, lengthy-time period, and the high failure rate are forcing researchers and drug manufacturing companies to look for newer technology, which can improve the process and reduce the cost at the same time. Mass spectrometry has the potential to do the same. It makes a functional and structural study, which takes a significant amount of time and resources in drug development, for the molecule, easier and faster. The funding and government initiatives in the region boost market growth.
To understand geography trends, Download Sample Report.
The mass spectrometry market is highly competitive and consists of a few major players. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Technological Advancement
4.2.2 Growing Concerns Over Food Safety
4.2.3 Rising R&D Expenditure By Pharmaceutical Industry & Government Research Organizations
4.3 Market Restraints
4.3.1 High Cost Of Instrument
4.3.2 Lack Of Skilled Technicians
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Technology
5.1.1 Hybrid Mass Spectrometry
22.214.171.124 Triple Quadrupole (Tandem)
126.96.36.199 Quadrupole TOF (Q-TOF)
188.8.131.52 FTMS (Fourier Transform Mass Spectrometry)
5.1.2 Single Mass Spectrometry
184.108.40.206 ION Trap
220.127.116.11 Time-of-Flight (TOF)
5.1.3 Other Mass Spectrometry
5.2 By Application
5.2.1 Pharmaceuticals Industry
5.2.2 Biotechnology Industry
5.2.3 Chemical Industry
5.2.4 Other Applications
5.3.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle-East & Africa
5.3.5 South America
22.214.171.124 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies
6.1.2 Bruker Corporation
6.1.3 Danaher Corporation
6.1.4 Dani Instruments
6.1.5 Leco Corporation
6.1.6 Perkin elmer Inc.
6.1.7 Shimadzu Corporation
6.1.8 Thermo Fisher Scientific
6.1.9 Waters Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments